156-Woodland International Research Group, LLC — Little Rock, Arkansas

156-Woodland International Research Group, LLC is a clinical research site located in Little Rock, Arkansas, United States 72211.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

156-Woodland International Research Group, LLC has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: ACADIA Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 156-Woodland International Research Group, LLC?

156-Woodland International Research Group, LLC has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 156-Woodland International Research Group, LLC conducted?

156-Woodland International Research Group, LLC has 1 clinical trials on record. Their work covers Schizophrenia.

Is 156-Woodland International Research Group, LLC accredited by Crixeo Health?

156-Woodland International Research Group, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 156-Woodland International Research Group, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.